Brief: Pharma Equity Group Maintains 2024 Guidance
Aug 16 (Reuters) - Pharma Equity Group A/S PEGRP.CO :
* MAINTAIN PREVIOUSLY ANNOUNCED GUIDANCE FOR 2024
* H1 LOSS AFTER TAX OF DKK 13.0 MLN, WHICH IS IN LINE WITH
EXPECTATIONS FOR PERIOD
Source text for Eikon: ID:nGNE2SCvQB
Further company coverage: PEGRP.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Pharma Equity A/S
See all newsBrief: PEG: Interpatium Commences Proceedings To Set Aside Arbitral Award
Brief: Pharma Equity Maintains Financial Guidance For 2026
Brief: Pharma Equity Group Unit Gets Patent Grant Notification
Brief: Pharma Equity Group To Borrow Up To About DKK 9.63 Million
Brief: Pharma Equity Group Adjusts 2025 Expectations